Record Q2 Sales of $4.9 million, Q2 Net Earnings of $0.7 million MISSISSAUGA, May 12, 2022 - Microbix Biosystems Inc. (TSX: MBX, OTCQX:...

Record Q2 Sales of $4.9 million, Q2 Net Earnings of $0.7 million MISSISSAUGA, May 12, 2022 - Microbix Biosystems Inc. (TSX: MBX, OTCQX:...
QAPs Supporting Molecular Diagnostic Tests for Dominant COVID-variant MISSISSAUGA, CANADA, April 29, 2022 – Microbix Biosystems Inc. (TSX:...
Healthcare Investor Conference in Toronto on May 2 & 3, 2022 MISSISSAUGA, CANADA, April 28, 2022 – Microbix Biosystems Inc. (TSX: MBX,...
QAPs Supporting Tests That Simultaneously Detect Multiple Respiratory Viruses MISSISSAUGA, CANADA, April 19, 2022 – Microbix Biosystems...
QAPs Supporting Screening-Tests for High-Risk Human Papilloma Viruses MISSISSAUGA, CANADA, April 8, 2022 – Microbix Biosystems Inc. (TSX:...
Microbix Announces Annual and Special Meeting Voting Results MISSISSAUGA, CANADA, March 31, 2022 - Microbix Biosystems Inc. (TSX: MBX,...
Implementing MasterControl® and NetSuite® Solutions to Enable Rapid Growth MISSISSAUGA, CANADA, March 29, 2022 – Microbix Biosystems Inc....
Using Shareholder-Approved Plan to Incentivize and Retain MISSISSAUGA, CANADA, February 24, 2022 - Microbix Biosystems Inc. (TSX: MBX,...
For Appointment of Jennifer Stewart, Accomplished Business Leader MISSISSAUGA, CANADA, February 22, 2022 – Microbix Biosystems Inc. (TSX:...
Meetings with Growth-Oriented Investors, February 18-20, 2022 MISSISSAUGA, CANADA, February 17, 2022 - Microbix Biosystems Inc. (TSX: MBX,...
Expansion of Capacity for Manufacturing of QAPs & DxTM MISSISSAUGA, CANADA, February 15, 2022 – Microbix Biosystems Inc. (TSX: MBX,...
Record Q1 Sales of $4.9 million, Record Q1 Net Earnings of $0.9 million MISSISSAUGA, February 10, 2022 - Microbix Biosystems Inc. (TSX:...